Michael Hunt, CFO at ReNeuron PLC (LON:RENE) sat down with Proactive's Andrew Scott on the day of their results for the year to the end of March 2017 to bring us up to speed on the latest with their therapeutic development programmes.
It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study
Quick facts: ReNeuron Group PLC
Price: 92.5 GBX
Market Cap: £29.48 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of ReNeuron Group PLC named herein, including the promotion by the Company of ReNeuron Group PLC in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE